# Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH

> **NCT04098250** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 6 (actual)

## Conditions studied

- Post-Traumatic Headache

## Interventions

- **DRUG:** Erenumab
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04098250
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-04
- **Primary completion:** 2024-01-10
- **Final completion:** 2024-01-10
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-10-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04098250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04098250, "Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04098250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*